{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-23-000060","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.374851+00:00","generated_at":"2026-06-16T02:56:21.323327+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Penumbra Q1 revenue $241.4M (+18.4%); raises FY 2023 guidance to $1.04-1.06B","bullets":["Revenue $241.4M (+18.4% YoY, +19.7% constant currency); vascular $142.8M, neuro $98.5M.","Gross margin 62.6%; operating income $8.0M vs loss of $4.0M YoY.","Non-GAAP operating income $10.4M vs non-GAAP loss of $2.3M YoY.","Raised full-year 2023 revenue guidance: $1.04B to $1.06B (23% to 25% growth).","Vascular growth expected slightly above guidance range; Neuro growth below."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-23-000060","json":"https://secwatch.observer/filing/0001321732-23-000060.json","markdown":"https://secwatch.observer/filing/0001321732-23-000060.md","text":"https://secwatch.observer/filing/0001321732-23-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000060/0001321732-23-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000060/pen-20230502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T02:56:21.323327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e58b9b9a32abaea5a2860e97a06294f54eacfad2","claim":"Penumbra Inc reported the first quarter ended March 31, 2023 results: revenue $241.4 million. Guidance raised.","evidence_excerpt":"Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2023. • Revenue of $241.4 million in the first quarter of 2023, an increase of 18.4%, or 19.7% in constant currency 1 , compared to the first quarter of 2022. First Quarter 2023 Financial Results Total revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000060/0001321732-23-000060-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$241.4 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}